269 related articles for article (PubMed ID: 12391099)
1. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1.
Ohga E; Tomita T; Wada H; Yamamoto H; Nagase T; Ouchi Y
J Appl Physiol (1985); 2003 Jan; 94(1):179-84. PubMed ID: 12391099
[TBL] [Abstract][Full Text] [Related]
2. Effect of nasal continuous positive airway pressure treatment on plasma adrenomedullin levels in patients with obstructive sleep apnea syndrome: roles of nocturnal hypoxia and oxidant stress.
Yamamoto H; Teramoto S; Yamaguchi Y; Ouchi Y
Hypertens Res; 2007 Nov; 30(11):1065-76. PubMed ID: 18250556
[TBL] [Abstract][Full Text] [Related]
3. Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome.
Ursavaş A; Karadağ M; Rodoplu E; Yilmaztepe A; Oral HB; Gözü RO
Respiration; 2007; 74(5):525-32. PubMed ID: 17148932
[TBL] [Abstract][Full Text] [Related]
4. Long-term oxygen administration reduces plasma adrenomedullin levels in patients with obstructive sleep apnea syndrome.
Yamamoto H; Teramoto S; Yamaguchi Y; Hanaoka Y; Ishii M; Hibi S; Ouchi Y
Sleep Med; 2007 Dec; 9(1):80-7. PubMed ID: 17512795
[TBL] [Abstract][Full Text] [Related]
5. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome.
Ohga E; Nagase T; Tomita T; Teramoto S; Matsuse T; Katayama H; Ouchi Y
J Appl Physiol (1985); 1999 Jul; 87(1):10-4. PubMed ID: 10409552
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of MCP-1 and adiponectin in obstructive sleep apnea syndrome.
Kim J; Lee CH; Park CS; Kim BG; Kim SW; Cho JH
Arch Otolaryngol Head Neck Surg; 2010 Sep; 136(9):896-9. PubMed ID: 20855682
[TBL] [Abstract][Full Text] [Related]
7. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome.
Ryan S; Taylor CT; McNicholas WT
Am J Respir Crit Care Med; 2006 Oct; 174(7):824-30. PubMed ID: 16840748
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure.
Yokoe T; Minoguchi K; Matsuo H; Oda N; Minoguchi H; Yoshino G; Hirano T; Adachi M
Circulation; 2003 Mar; 107(8):1129-34. PubMed ID: 12615790
[TBL] [Abstract][Full Text] [Related]
9. NT-pro-BNP in obstructive sleep apnea syndrome is decreased by nasal continuous positive airway pressure.
Tasci S; Manka R; Scholtyssek S; Lentini S; Troatz C; Stoffel-Wagner B; Lüderitz B
Clin Res Cardiol; 2006 Jan; 95(1):23-30. PubMed ID: 16598442
[TBL] [Abstract][Full Text] [Related]
10. Association between Interleukin-6 and vitamin D serum levels in patients with obstructive sleep apnea syndrome and impact of long-term continuous positive airway pressure therapy on biomarker levels.
Kotsiou OS; Siachpazidou DI; Pastaka C; Gogou E; Stavrou V; Kechagia M; Varsamas C; Hatzoglou C; Gourgoulianis KI
Respir Physiol Neurobiol; 2022 Feb; 296():103806. PubMed ID: 34678476
[TBL] [Abstract][Full Text] [Related]
11. Effect of nasal continuous positive airway pressure in men on global left ventricular myocardial performance in patients with obstructive sleep apnea syndrome.
Koga S; Ikeda S; Urata J; Kohno S
Am J Cardiol; 2008 Jun; 101(12):1796-800. PubMed ID: 18549862
[TBL] [Abstract][Full Text] [Related]
12. The impact of obstructive sleep apnea and nasal CPAP on circulating adiponectin levels.
Yoshikawa M; Yamauchi M; Fujita Y; Koyama N; Fukuoka A; Tamaki S; Yamamoto Y; Tomoda K; Kimura H
Lung; 2014 Apr; 192(2):289-95. PubMed ID: 24395128
[TBL] [Abstract][Full Text] [Related]
13. [Effects of nasal continuous positive airway pressure short-term treatment on C-reactive protein and intercellular adhesion molecule-1 in patients with obstructive sleep apnea-hypopnea syndrome].
Wang YN; Yang Y; Luo YQ; Chen LL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):666-9. PubMed ID: 16708805
[TBL] [Abstract][Full Text] [Related]
14. Effect of continuous positive airway pressure therapy on hypothalamic-pituitary-adrenal axis function and 24-h blood pressure profile in obese men with obstructive sleep apnea syndrome.
Carneiro G; Togeiro SM; Hayashi LF; Ribeiro-Filho FF; Ribeiro AB; Tufik S; Zanella MT
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E380-4. PubMed ID: 18523125
[TBL] [Abstract][Full Text] [Related]
15. Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndrome.
Nakagawa Y; Kishida K; Kihara S; Sonoda M; Hirata A; Yasui A; Nishizawa H; Nakamura T; Yoshida R; Shimomura I; Funahashi T
Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E778-84. PubMed ID: 18198351
[TBL] [Abstract][Full Text] [Related]
16. Production of inflammatory mediators by monocytes in patients with obstructive sleep apnea syndrome.
Tamaki S; Yamauchi M; Fukuoka A; Makinodan K; Koyama N; Tomoda K; Yoshikawa M; Kimura H
Intern Med; 2009; 48(15):1255-62. PubMed ID: 19652426
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of nasal continuous positive airway pressure on vasodilatory endothelial function in obstructive sleep apnea syndrome.
Duchna HW; Orth M; Schultze-Werninghaus G; Guilleminault C; Stoohs RA
Sleep Breath; 2005 Sep; 9(3):97-103. PubMed ID: 16021522
[TBL] [Abstract][Full Text] [Related]
18. Continuous positive nasal airway pressure decreases levels of serum amyloid A and improves autonomic function in obstructive sleep apnea syndrome.
Kuramoto E; Kinami S; Ishida Y; Shiotani H; Nishimura Y
Int J Cardiol; 2009 Jul; 135(3):338-45. PubMed ID: 18584894
[TBL] [Abstract][Full Text] [Related]
19. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome.
Minoguchi K; Tazaki T; Yokoe T; Minoguchi H; Watanabe Y; Yamamoto M; Adachi M
Chest; 2004 Nov; 126(5):1473-9. PubMed ID: 15539715
[TBL] [Abstract][Full Text] [Related]
20. Mouth breathing in obstructive sleep apnea prior to and during nasal continuous positive airway pressure.
Ruhle KH; Nilius G
Respiration; 2008; 76(1):40-5. PubMed ID: 18042974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
